Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Insights - The report highlights that a new round of price increases for pigs may gradually begin, with the African swine fever vaccine opening growth opportunities for the animal health sector [4][5] - The report emphasizes that the investment logic for live pigs is marginally improving, supported by both fundamental and policy factors, with recommendations for specific companies [5][31] Summary by Sections Weekly Observation - As of August 15, 2025, the national average price of live pigs is 13.73 CNY/kg, with a week-on-week increase of 0.06 CNY/kg but a year-on-year decrease of 7.44% [4][13] - The price premium for 150kg fat pigs over 120kg standard pigs is 0.28 CNY/kg, indicating a tightening supply [4][13] Weekly Market Performance (August 11-15) - The agricultural sector underperformed the market by 1.84 percentage points, with the agricultural index down 0.14% while the Shanghai Composite Index rose by 1.70% [6][35] - Key stocks that led the gains include COFCO Sugar (+41.04%), Shunli Biological (+13.97%), and Xiaoming Co. (+8.86%) [6][35] Price Tracking (August 11-15) - The average price of live pigs on August 15 is 13.76 CNY/kg, a slight increase from the previous week [6][46] - The average price of piglets is 28.87 CNY/kg, showing a decrease of 5.03% from the previous week [6][46] - The average price of white feathered chickens is 7.20 CNY/kg, with a week-on-week increase of 0.84% [6][51] Key News (August 11-15) - The central government allocated 1.146 billion CNY for agricultural disaster relief, supporting major grain-producing provinces [6][41]

Investment Rating - The industry is rated as "Overweight," indicating that the growth level of the industry is expected to exceed that of the CSI 300 index in the next six months [75]. Core Insights - The animal health industry is anticipated to recover alongside improvements in the breeding sector, driven by the approval of clinical trials for African swine fever vaccines, which could significantly expand the market [7][10]. - The breeding industry has shown mixed performance, with some companies reporting increased sales and profits, while others face challenges due to fluctuating prices and weights of livestock [8][9]. - The global grain supply and demand dynamics are being affected by geopolitical factors, with adjustments in production forecasts for wheat, rice, corn, and soybeans for the 2025/26 season [11][12][13][14]. Summary by Sections Animal Health Industry - The approval of clinical trials for African swine fever vaccines is a significant development, with a potential market size of 14.5 billion expected by 2027 [23]. - Several animal health companies have forecasted substantial profit growth for the first half of 2025, with increases ranging from 40% to 70% year-on-year [7]. Breeding Industry - In June, the total sales of pigs from 12 companies reached 7.4472 million heads, a month-on-month decrease of 3.21%, while the average price per kilogram was 14.32 yuan, down 1.92% [8]. - The average weight of pigs sold decreased to 101.8 kg, a drop of 7.84% month-on-month, indicating challenges in the breeding sector [8]. Grain Supply and Demand - The global wheat supply is projected to decrease by 400,000 tons to 107.21 million tons for the 2025/26 season, while consumption is expected to rise by 800,000 tons to 81.06 million tons [11]. - The rice supply remains stable, but consumption is forecasted to reach a record 54.16 million tons, driven by increased demand from China [12]. - The corn market is seeing increased production in Canada and Mexico, while global corn stocks are expected to decrease by 3.2 million tons to 27.21 million tons [13]. - The soybean market is projected to see an increase in supply and crushing, with ending stocks expected to rise by 800,000 tons to 12.61 million tons [14]. Seed Industry - The revitalization of the seed industry is supported by government policies aimed at enhancing crop yields and promoting the commercialization of biotechnology [15]. - Companies with advantages in biotechnology and seed varieties are expected to benefit from ongoing industry expansion [15]. Pet Industry - The domestic pet food market is projected to grow significantly, with compound annual growth rates of 17% for pet staples and 25% for pet snacks expected by 2026 [16]. - Leading domestic pet food companies are increasingly focusing on brand strategies and global expansion to enhance their market presence [16].

Core Viewpoint - The city of Hohhot is striving to become the leading hub for veterinary vaccine research and production in China, driven by significant technological breakthroughs and supportive policies in the biopharmaceutical industry [1][3][5] Group 1: Technological Breakthroughs - Jin Yu Bao Ling Biopharmaceutical Co., Ltd. launched the "Jin Niu Zhi" vaccine, marking a major technological advancement in China's biopharmaceutical sector [1] - The company has also established an intelligent manufacturing line capable of producing 8 million doses of pet vaccines annually, which has passed GMP static acceptance [1] - The establishment of the Inner Mongolia Animal Vaccine Technology Innovation Center aims to enhance vaccine research and development, focusing on major animal diseases [2][3] Group 2: Industry Growth and Collaboration - Hohhot has seen its biopharmaceutical industry output grow from 13.11 billion yuan in 2020 to 20.25 billion yuan in 2024, with 117 research institutions and 602 drug registration approvals [4] - The city has actively collaborated with prestigious institutions like the Chinese Academy of Sciences and Tsinghua University to accelerate vaccine development [4] - The introduction of high-value product projects by local companies aims to enhance the quality and innovation of animal serum and vaccine production [2][4] Group 3: Policy Support and Investment - Hohhot has implemented various policies to support the high-quality development of the biopharmaceutical industry, including financial incentives totaling 14 million yuan for innovation platforms and vaccine projects [3] - The city is positioning itself as a national leader in veterinary vaccine production, with significant investments in research and development infrastructure [5] - The establishment of the National Swine Technology Innovation Center in Inner Mongolia signifies the region's commitment to becoming a key player in the animal vaccine industry [4]